Medtronic plc has received the first FDA approval for a transcatheter pulmonary valve to treat patients whose bioprosthetic pulmonary heart valves have failed. For these congenital heart disease patients, many of whom undergo repeat open heart surgeries as children and into adulthood, this validates the use of the Melody Transcatheter Pulmonary Valve (TPV) to avoid additional surgical procedures.